全文获取类型
收费全文 | 40488篇 |
免费 | 2515篇 |
国内免费 | 120篇 |
专业分类
耳鼻咽喉 | 611篇 |
儿科学 | 1331篇 |
妇产科学 | 1067篇 |
基础医学 | 6405篇 |
口腔科学 | 734篇 |
临床医学 | 3616篇 |
内科学 | 8689篇 |
皮肤病学 | 916篇 |
神经病学 | 3957篇 |
特种医学 | 1704篇 |
外国民族医学 | 24篇 |
外科学 | 6037篇 |
综合类 | 155篇 |
一般理论 | 8篇 |
预防医学 | 2023篇 |
眼科学 | 697篇 |
药学 | 2289篇 |
中国医学 | 33篇 |
肿瘤学 | 2827篇 |
出版年
2023年 | 256篇 |
2022年 | 403篇 |
2021年 | 995篇 |
2020年 | 577篇 |
2019年 | 855篇 |
2018年 | 1041篇 |
2017年 | 756篇 |
2016年 | 957篇 |
2015年 | 1007篇 |
2014年 | 1352篇 |
2013年 | 1672篇 |
2012年 | 2461篇 |
2011年 | 2513篇 |
2010年 | 1305篇 |
2009年 | 1294篇 |
2008年 | 2087篇 |
2007年 | 2144篇 |
2006年 | 1933篇 |
2005年 | 1902篇 |
2004年 | 1594篇 |
2003年 | 1507篇 |
2002年 | 1368篇 |
2001年 | 1006篇 |
2000年 | 1034篇 |
1999年 | 874篇 |
1998年 | 428篇 |
1997年 | 323篇 |
1996年 | 275篇 |
1995年 | 256篇 |
1994年 | 225篇 |
1993年 | 217篇 |
1992年 | 535篇 |
1991年 | 570篇 |
1990年 | 543篇 |
1989年 | 453篇 |
1988年 | 419篇 |
1987年 | 437篇 |
1986年 | 424篇 |
1985年 | 408篇 |
1984年 | 296篇 |
1983年 | 242篇 |
1982年 | 171篇 |
1979年 | 278篇 |
1978年 | 199篇 |
1977年 | 167篇 |
1976年 | 160篇 |
1975年 | 170篇 |
1974年 | 206篇 |
1973年 | 177篇 |
1972年 | 167篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
81.
Dr. G. von Nagy 《Journal of molecular medicine (Berlin, Germany)》1924,3(7):274-276
Ohne Zusammenfassung 相似文献
82.
Lamine Abdennour Paola Sanchez-Pea Damien Galanaud Vincent Navarro Nicolas Weiss Louis Puybasset 《Neuropsychiatric Disease and Treatment》2007,3(5):695-702
As for the majority of antiepileptic drugs, encephalopathy, manifested by transient somnolence, mood and motor disorders, is a possible side-effect. To our knowledge, there is little information about gabapentin-induced coma. We report a third case of gabapentin-induced coma where magnetic resonance-spectrometry was performed in diagnosis assessment. 相似文献
83.
Bettina Seiberlich Nicolas Hunzelmann Axel Roers Manfred Weber Eckhard Schulze-Lohoff 《Medizinische Klinik》2005,108(4):137-142
Namensgebend für das Jo-1-Syndrom sind Autoantikörper gegen das Jo-1-Antigen, die bei diesem Krankheitsbild im Serum der betroffenen Patienten nachgewiesen werden. Der Name Jo-1 leitet sich von dem ersten Patienten (John P.) ab, bei dem diese Antikörper gefunden wurden. Dieser Patient litt an einer Polymyositis und fibrosierenden Alveolitis. Das Jo-1-Antigen ist identisch mit der Histidyl-Transfer-RNA-Synthetase im Zytosol. Das Jo-1-Syndrom gehört zu einer Familie von Autoimmunerkrankungen, die als Anti-Synthetase- Syndrome bezeichnet werden. Diese Syndrome haben gemeinsam, dass jeweils Autoantikörper gegen unterschiedliche Aminosäure-Transfer-RNASynthetasen nachweisbar sind. Klinisch handelt es sich beim Jo-1-Syndrom um eine Sonderform der Poly- bzw. Dermatomyositis von bisher ungeklärter Ätiologie. Neben einer Muskelbeteiligung kommt es charakteristischerweise zu einer interstitiellen Lungenbeteiligung, die auch prognostisch das Krankheitsbild bestimmt. Zusätzlich können klinisch eine Polyarthritis und weitere Symptome bestehen, die dem klinischen Bild anderer Kollagenosen ähneln. Ebenso wie die Polymyositis und Dermatomyositis kann sich das Jo-1-Syndrom in sog. Myositis-Overlap-Syndromen präsentieren. Zu dieser Diagnose führt ein Symptomenkomplex, der die klare Zuordnung zu einer einzelnen Erkrankung nicht möglich macht. Häufig werden in solchen Fällen U1-RNP-Antikörper nachgewiesen. Therapeutisch spricht das Jo-1-Syndrom auf die Gabe von Kortikosteroiden und—falls notwendig—Azathioprin, Methotrexat und Cyclophosphamid an. Eine Kurzbeschreibung von zwei klinischen Fällen stellt das Krankheitsbild anschaulich dar. 相似文献
84.
85.
Tobias von Lukowicz Michela Silacci Matthias T Wyss Eveline Trachsel Christine Lohmann Alfred Buck Thomas F Lüscher Dario Neri Christian M Matter 《Journal of nuclear medicine》2007,48(4):582-587
Targeting proteins that are overexpressed in atherosclerotic plaques may open novel diagnostic applications. The C domain of tenascin-C is absent from normal adult tissues but can be inserted during tumor progression or tissue repair into the molecule by alternative splicing. We tested the ability of the human antibody G11, specific to this antigen, to reveal murine atherosclerotic plaques ex vivo. The antibody directed against the extra domain B of fibronectin (L19) was used as a reference. METHODS: We intravenously injected (125)I-labeled G11 or L19 antibodies into apolipoprotein E-deficient (ApoE(-/-)) mice and harvested the aortae 4 or 24 h later. En face analyses of distal aortae and longitudinal sections of the aortic arch were performed to compare antibody uptake using autoradiography with plaque staining using oil red O. Plaque macrophages were detected by immunohistochemistry (anti-CD68 staining). Biodistribution of injected antibodies was investigated in aortae and blood at 4 and 24 h. RESULTS: En face analyses revealed a significant correlation between radiolabeled G11 and fat-stained areas, increasing from 4 to 24 h, with a correlation coefficient of 0.92 (P < 0.0001) and an average signal-to-noise ratio of 104:1 at 24 h. Plaque imaging using L19 showed similar results (r = 0.86; P < 0.0001; signal-to-noise ratio, 72:1 at 24 h). Uptake of radiolabeled antibodies in histologic sections colocalized with fat staining and activated macrophages in aortic plaques. Biodistribution analyses confirmed specific accumulation in aortic plaques as well as rapid blood pool clearance of the antibodies 24 h after injection. Immunofluorescence analyses revealed increased expression of tenascin and fibronectin isoforms in macrophage-rich plaques. CONCLUSION: The antibody G11, specific to the C domain of tenascin-C, visualizes murine atherosclerotic plaques ex vivo. In conjunction with the increased expression of the C domain of tenascin-C in macrophage-rich plaques, the colocalization of G11 uptake with activated macrophages, and the favorable target-to-blood ratio at 24 h, this antibody may be useful for molecular imaging of advanced atherosclerotic plaques in the intact organism. 相似文献
86.
Markus Donix Bettina Beuthien-Baumann Rüdiger von Kummer Georg Gahn Fatima Thomas Vjera Holthoff 《Journal of clinical neuroscience》2007,14(6):601-603
Waldenstrom's macroglobulinemia (WM) is an uncommon low-grade lymphoma. Cognitive impairment due to central nervous system infiltration by lymphoplasmocytoid cells (Bing-Neel syndrome) has been rarely reported. We describe a 54-year-old man who was referred to a memory disorder clinic with a 9-month history of clinically obvious nonfluent aphasia and WM. He underwent extensive neuropsychological testing, clinical examination and structural and functional brain imaging. The diagnosis of the diffuse form of the Bing-Neel syndrome was supported by abnormal lymphoid cells found in the cerebrospinal fluid. Structural and functional brain imaging revealed impairment of brain areas due to white matter changes and subsequent functional deficits mimicking the neuropsychological syndrome encountered in progressive nonfluent aphasia. The diffuse form of Bing-Neel syndrome and neurological deficits are assumed to be the result of leptomeningeal infiltration by malignant cells and/or neoplastic vascular obstruction. 相似文献
87.
Immunological and echocardiographic evaluation of decellularized versus cryopreserved allografts during the Ross operation. 总被引:3,自引:0,他引:3
Francisco Diniz Affonso da Costa Pascal Maria Dohmen Daniele Duarte Cristina von Glenn Sérgio Veiga Lopes Hermínio Haggi Filho Marise Brenner Affonso da Costa Wolfgang Konertz 《European journal of cardio-thoracic surgery》2005,27(4):572-578
OBJECTIVE: Compare the immunological and echocardiographic data of decellularized versus cryopreserved allografts used for RVOT reconstruction during Ross operation. METHODS: From 16/01/03 thru 07/10/03, 20 Ross operations were performed using decellularized (n=11) or cryopreserved (n=9) allografts. Echocardiography was done at discharge, 1, 3, 6 and 12 months and annually thereafter. Samples for determination of antibodies against HLA class I and II were obtained preoperatively and at days 5, 10, 30, 90 and 180 postoperatively. These samples were tested by the ELISA method in LAT-M dishes (unspecific) for identification of circulating antibodies and the results expressed as mean sample values (Is=DO/cutoff). If positive, LAT-E (specific) was performed and PRA levels determined. RESULTS: There was no mortality. Cryopreserved allografts showed marked Is values elevations for class I and II antibodies which started at the first month and remained elevated up to 6 months. In contrast, of the patients receiving decellularized allografts, seven remained negative, two patients had only marginal elevation of class I antibodies and two patients showed abnormal elevations of PRA levels. This response happened earlier than in the cryopreserved group, starting on the 5th postoperative day and has returned to baseline levels in one case. Echocardiography showed mild, but significant, elevation of gradients in cryopreserved valves but none in the decellularized. CONCLUSIONS: Decellularized allografts had normal function up to 18 months and showed important reduction of the immunogenic response when compared to cryopreserved valves. 相似文献
88.
89.
90.